REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanimat, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores
Full name: Sanimat, S.R.O. Profile Updated: October 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sanimat, S.R.O. is based in Slovakia, with the head office in Bratislava. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on May 25, 2004. There was a net sales revenue increase of 25.35% reported in Sanimat, S.R.O.’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 6.69%. In 2023, Sanimat, S.R.O.’s net profit margin increased by 64.06%.

Headquarters
Budatinska, 16A
Bratislava; Bratislavsky; Postal Code: 85106

Contact Details: Purchase the Sanimat, S.R.O. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sanimat, S.R.O. report to view the information.
Registered Capital:
Purchase the Sanimat, S.R.O. report to view the information.
Incorporation Date:
May 25, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
85.71%
Purchase this report to view the information.
14.29%
Company Performance
Financial values in the chart are available after Sanimat, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
25.35%
Total operating revenue
25.39%
Operating profit (EBIT)
77.08%
EBITDA
N/A
Net Profit (Loss) for the Period
74.8%
Total assets
-6.69%
Total equity
-5.37%
Operating Profit Margin (ROS)
62.8%
Net Profit Margin
64.06%
Return on Equity (ROE)
15.68%
Quick Ratio
6.18%
Cash Ratio
2.91%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?